Menu
Search
Home > Courses > Current Controversies in Antiretroviral Therapy

Current Controversies in Antiretroviral Therapy

Current Controversies in Antiretroviral Therapy
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 3/15/2011
Review Date: 3/15/2011
Presenter
  • Roy M. Gulick, MD, MPH
    Rochelle Belfer Professor in Medicine, Chief, Division of Infectious Diseases, Weill Cornell Medicine
    Weill Medical College of Cornell University, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Be aware of newer antiretroviral agents.
  2. Discuss the latest data on strategies for starting antiretroviral therapy and what to start with.
  3. Discuss the latest data on when to change antiretroviral therapy and what to change to.
Presenter Bio
Roy Gulick, MD, MPH
Roy M. Gulick, MD, MPH is the Rochelle Belfer Professor of Medicine and Chief of the Division of Infectious Diseases in the Department of Medicine at Weill Cornell Medicine/New York-Presbyterian Hospital. He is Principal Investigator of the NIH-funded Weill Cornell-New Jersey Medical School HIV Clinical Trials Unit and serves as the Co-Chair of the US DHHS Antiretroviral Treatment Guidelines Panel. He is an internationally-recognized leader in clinical research in HIV.
PRN Learning Modules